Physicians' Academy for Cardiovascular Education

Changing paradigms in LDL-c reduction

10' education - Sep. 28, 2022 - Prof. Kausik Ray, MD - London, UK

Video navigation menu

  • Evidence in multiple forms 0:21
  • ApoB/LDL-c clearance is key 1:37
  • Reducing CV risk 3:53
  • Real-world data 6:04
  • Combination therapy 7:19


Show transcript

Educational information

This lecture by Prof. Ray was part of the EBAC-accredited symposium "A decade of innovation, guidelines, and paradigm shifts in LDL-c management" held during the ESC congress 2022.


Prof. Kausik Ray, MD, is Professor of Public Health/ Consultant Cardiologist at Imperial College London, United Kingdom and president of the European Atherosclerosis Society, .


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by unrestricted educational grants from Daiichi-Sankyo, New Amsterdam Pharma, Novartis, Sanofi & Ultragenyx.

View slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: